1 Table of Contents 3
|1.1 List of Tables 11
|1.2 List of Figures 26
2 Introduction 27
2.1 Transdermal Drug Delivery Overview 27
3 Products under Development 28
3.1 Transdermal Drug Delivery – Pipeline Products by Stage of Development 28
3.2 Transdermal Drug Delivery – Pipeline Products by Segment 29
3.3 Transdermal Drug Delivery – Pipeline Products by Territory 30
3.4 Transdermal Drug Delivery – Pipeline Products by Regulatory Path 32
3.5 Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date 33
3.6 Transdermal Drug Delivery – Ongoing Clinical Trials 34
4 Transdermal Drug Delivery – Pipeline Products under Development by Companies 35
4.1 Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development 35
4.2 Transdermal Drug Delivery – Pipeline Products by Stage of Development 41
5 Transdermal Drug Delivery Companies and Product Overview 48
5.1 4P Therapeutics LLC Company Overview 48
5.1.1 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.2 Actuated Medical Inc Company Overview 57
5.2.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.3 Adynxx Inc Company Overview 58
5.3.1 Adynxx Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.4 Aequus Pharmaceuticals Inc Company Overview 59
5.4.1 Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.5 AerMedX Ltd Company Overview 63
5.5.1 AerMedX Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
5.6 Agile Therapeutics Inc Company Overview 64
5.6.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.7 Allergan Ltd Company Overview 67
5.7.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
5.8 American Chemical Society Company Overview 69
5.8.1 American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview 69
5.9 AMW GmbH Company Overview 70
5.9.1 AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview 70
5.10 Apogee Technology Inc Company Overview 72
5.10.1 Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 72
5.11 Asahi Kasei Pharma Corp Company Overview 73
5.11.1 Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 73
5.12 ASCIL Biopharm Company Overview 74
5.12.1 ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview 74
5.13 Avecho Biotechnology Ltd Company Overview 75
5.13.1 Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
5.14 Avro Life Sciences Company Overview 78
5.14.1 Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 78
5.15 Boryung Pharmaceutical Co Ltd Company Overview 80
5.15.1 Boryung Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
5.16 Burke Pharmaceuticals LLC Company Overview 81
5.16.1 Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.17 Candesant Biomedical Inc Company Overview 83
5.17.1 Candesant Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 83
5.18 Cassava Sciences Inc Company Overview 86
5.18.1 Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 86
5.19 CB Scientific Inc Company Overview 87
5.19.1 CB Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 87
5.20 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview 88
5.20.1 Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 88
5.21 Chrono Therapeutics Inc Company Overview 89
5.21.1 Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 89
5.22 Cipla Ltd Company Overview 90
5.22.1 Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview 90
5.23 Clexio Biosciences Ltd Company Overview 91
5.23.1 Clexio Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
5.24 Corium Inc Company Overview 92
5.24.1 Corium Inc Pipeline Products & Ongoing Clinical Trials Overview 92
5.25 Daewoong Pharmaceutical Co Ltd Company Overview 98
5.25.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98
5.26 DBV Technologies SA Company Overview 99
5.26.1 DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 99
5.27 DD Therapeutics LLC Company Overview 104
5.27.1 DD Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 104
5.28 Delpor Inc Company Overview 105
5.28.1 Delpor Inc Pipeline Products & Ongoing Clinical Trials Overview 105
5.29 Dermisonics Inc Company Overview 109
5.29.1 Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview 109
5.30 Dharma Therapeutics, Inc. (Inactive) Company Overview 110
5.30.1 Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 110
5.31 Diomics Corp Company Overview 111
5.31.1 Diomics Corp Pipeline Products & Ongoing Clinical Trials Overview 111
5.32 Drexel University Company Overview 112
5.32.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 112
5.33 Drug Delivery Co LLC Company Overview 113
5.33.1 Drug Delivery Co LLC Pipeline Products & Ongoing Clinical Trials Overview 113
5.34 DURECT Corp Company Overview 114
5.34.1 DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview 114
5.35 Echo Therapeutics Inc Company Overview 116
5.35.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116
5.36 Emplicure AB Company Overview 117
5.36.1 Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview 117
5.37 Endo International Plc Company Overview 118
5.37.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 118
5.38 Endomimetics LLC Company Overview 119
5.38.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.39 Extend Biosciences Inc Company Overview 120
5.39.1 Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 120
5.40 Fe3 Medical Inc Company Overview 121
5.40.1 Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 121
5.41 Futura Medical Plc Company Overview 122
5.41.1 Futura Medical Plc Pipeline Products & Ongoing Clinical Trials Overview 122
5.42 Georgia Institute of Technology Company Overview 126
5.42.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 126
5.43 Georgia State University Company Overview 129
5.43.1 Georgia State University Pipeline Products & Ongoing Clinical Trials Overview 129
5.44 GlobeStar Therapeutics Corp Company Overview 130
5.44.1 GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 130
5.45 Hisamitsu Pharmaceutical Co Inc Company Overview 131
5.45.1 Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview 131
5.46 I M Sechenov Moscow State Medical University Company Overview 136
5.46.1 I M Sechenov Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview 136
5.47 Icure Pharmaceutical Inc Company Overview 137
5.47.1 Icure Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 137
5.48 ImmunoMatrix LLC Company Overview 141
5.48.1 ImmunoMatrix LLC Pipeline Products & Ongoing Clinical Trials Overview 141
5.49 ImmuPatch Company Overview 142
5.49.1 ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview 142
5.50 Indian Institute of Science Company Overview 144
5.50.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 144
5.51 Indian Institute of Technology Bombay Company Overview 145
5.51.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 145
5.52 Indian Institute of Technology Hyderabad Company Overview 146
5.52.1 Indian Institute of Technology Hyderabad Pipeline Products & Ongoing Clinical Trials Overview 146
5.53 InMed Pharmaceuticals Inc Company Overview 147
5.53.1 InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.54 Institute of Materials Research & Engineering Company Overview 148
5.54.1 Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview 148
5.55 Intercell AG (Inactive) Company Overview 149
5.55.1 Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 149
5.56 Interstitial NS Company Overview 150
5.56.1 Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview 150
5.57 Isis Biopolymer Inc (Inactive) Company Overview 151
5.57.1 Isis Biopolymer Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 151
5.58 Janisys Company Overview 153
5.58.1 Janisys Pipeline Products & Ongoing Clinical Trials Overview 153
5.59 Jiaxing Xinwen Biotechnology Co Ltd Company Overview 154
5.59.1 Jiaxing Xinwen Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 154
5.60 Jubilee Biotech Company Overview 156
5.60.1 Jubilee Biotech Pipeline Products & Ongoing Clinical Trials Overview 156
5.61 Kailian Medical Technology Co Ltd Company Overview 157
5.61.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 157
5.62 Karolinska Institute Company Overview 158
5.62.1 Karolinska Institute Pipeline Products & Ongoing Clinical Trials Overview 158
5.63 Kindeva Drug Delivery LP Company Overview 159
5.63.1 Kindeva Drug Delivery LP Pipeline Products & Ongoing Clinical Trials Overview 159
5.64 KTH Royal Institute of Technology Company Overview 160
5.64.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 160
5.65 Leo Pharma AS Company Overview 161
5.65.1 Leo Pharma AS Pipeline Products & Ongoing Clinical Trials Overview 161
5.66 Livzon Pharmaceutical Group Co Ltd Company Overview 164
5.66.1 Livzon Pharmaceutical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 164
5.67 Lohmann Therapie-Systeme AG Company Overview 165
5.67.1 Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview 165
5.68 Luye Pharma Group Ltd Company Overview 167
5.68.1 Luye Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 167
5.69 Massachusetts Institute of Technology Company Overview 170
5.69.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 170
5.70 Mayne Pharma Group Ltd Company Overview 171
5.70.1 Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 171
5.71 Medherant Ltd Company Overview 172
5.71.1 Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview 172
5.72 MEDRx Co Ltd Company Overview 177
5.72.1 MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 177
5.73 MedRx, Inc. Company Overview 183
5.73.1 MedRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 183
5.74 Microdermics Inc Company Overview 184
5.74.1 Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview 184
5.75 Micron Biomedical Inc Company Overview 185
5.75.1 Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 185
5.76 Micropoint Technologies Pte Ltd Company Overview 189
5.76.1 Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 189
5.77 Mineed Technology Co Ltd Company Overview 190
5.77.1 Mineed Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 190
5.78 mPhase Technologies Inc Company Overview 191
5.78.1 mPhase Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 191
5.79 Mycrodose Therapeutics Inc Company Overview 192
5.79.1 Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 192
5.80 MyLife Technologies Company Overview 194
5.80.1 MyLife Technologies Pipeline Products & Ongoing Clinical Trials Overview 194
5.81 Nanyang Technological University Company Overview 195
5.81.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 195
5.82 National Dental Centre Singapore Company Overview 196
5.82.1 National Dental Centre Singapore Pipeline Products & Ongoing Clinical Trials Overview 196
5.83 National University of Singapore Company Overview 197
5.83.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 197
5.84 Nemaura Pharma Ltd Company Overview 199
5.84.1 Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.85 NeuroDerm Ltd Company Overview 207
5.85.1 NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview 207
5.86 Nitto Denko Corp Company Overview 209
5.86.1 Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview 209
5.87 North Carolina State University Company Overview 212
5.87.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 212
5.88 Noven Pharmaceuticals Inc Company Overview 214
5.88.1 Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 214
5.89 NutriBand Inc Company Overview 216
5.89.1 NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview 216
5.90 Nuvo Pharmaceuticals Inc Company Overview 221
5.90.1 Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 221
5.91 Osprey Medical Inc Company Overview 222
5.91.1 Osprey Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 222
5.92 Pantec Biosolutions AG Company Overview 223
5.92.1 Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 223
5.93 PassPort Technologies Inc Company Overview 227
5.93.1 PassPort Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 227
5.94 PharmaTher Holdings Ltd Company Overview 228
5.94.1 PharmaTher Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 228
5.95 Privo Technologies Inc Company Overview 231
5.95.1 Privo Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 231
5.96 Prometheon Pharma LLC Company Overview 232
5.96.1 Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 232
5.97 Purdue University Company Overview 235
5.97.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 235
5.98 Quadmedicine Company Overview 237
5.98.1 Quadmedicine Pipeline Products & Ongoing Clinical Trials Overview 237
5.99 Quoin Pharmaceuticals Inc Company Overview 239
5.99.1 Quoin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 239
5.100 Radius Health Inc Company Overview 241
5.100.1 Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview 241
5.101 Ryah Medtech Inc Company Overview 242
5.101.1 Ryah Medtech Inc Pipeline Products & Ongoing Clinical Trials Overview 242
5.102 Samyang Biopharmaceuticals Corp Company Overview 243
5.102.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 243
5.103 Sanofi Company Overview 244
5.103.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 244
5.104 Seelos Therapeutics, Inc. Company Overview 245
5.104.1 Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 245
5.105 Shenox Pharmaceuticals LLC Company Overview 246
5.105.1 Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 246
5.106 Sinsin Pharmaceutical Co Ltd Company Overview 251
5.106.1 Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 251
5.107 SK Chemicals Co Ltd Company Overview 254
5.107.1 SK Chemicals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 254
5.108 Skinject Inc Company Overview 255
5.108.1 Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview 255
5.109 Sorrento Therapeutics Inc Company Overview 258
5.109.1 Sorrento Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 258
5.110 Sparsha Pharma International Pvt Ltd Company Overview 259
5.110.1 Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 259
5.111 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 260
5.111.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 260
5.112 Stanford University Company Overview 261
5.112.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 261
5.113 Starton Therapeutics Inc Company Overview 263
5.113.1 Starton Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 263
5.114 Swansea University Company Overview 272
5.114.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 272
5.115 Syntropharma Ltd Company Overview 273
5.115.1 Syntropharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 273
5.116 Taho Pharmaceuticals Ltd Company Overview 275
5.116.1 Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 275
5.117 Technology Health Inc Company Overview 278
5.117.1 Technology Health Inc Pipeline Products & Ongoing Clinical Trials Overview 278
5.118 Teikoku Pharma USA Inc Company Overview 279
5.118.1 Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview 279
5.119 tesa Labtec GmbH Company Overview 283
5.119.1 tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 283
5.120 Teva Pharmaceutical Industries Ltd Company Overview 285
5.120.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 285
5.121 Texas Tech University Company Overview 286
5.121.1 Texas Tech University Pipeline Products & Ongoing Clinical Trials Overview 286
5.122 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 287
5.122.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 287
5.123 TheraJect Inc Company Overview 288
5.123.1 TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview 288
5.124 TheraSolve NV (Inactive) Company Overview 289
5.124.1 TheraSolve NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 289
5.125 Theratech, Inc. Company Overview 290
5.125.1 Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 290
5.126 Theris Medical Inc Company Overview 291
5.126.1 Theris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 291
5.127 Thrudermic LLC Company Overview 292
5.127.1 Thrudermic LLC Pipeline Products & Ongoing Clinical Trials Overview 292
5.128 Titan Pharmaceuticals Inc Company Overview 293
5.128.1 Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 293
5.129 Toa Eiyo Ltd Company Overview 294
5.129.1 Toa Eiyo Ltd Pipeline Products & Ongoing Clinical Trials Overview 294
5.130 Transcu Group Limited (Inactive) Company Overview 295
5.130.1 Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 295
5.131 Transdermal Delivery Solutions Corp Company Overview 296
5.131.1 Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview 296
5.132 TransPharma Medical Ltd (Inactive) Company Overview 302
5.132.1 TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 302
5.133 Transport Pharmaceuticals Inc Company Overview 304
5.133.1 Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 304
5.134 University of Helsinki Company Overview 305
5.134.1 University of Helsinki Pipeline Products & Ongoing Clinical Trials Overview 305
5.135 University of Illinois at Chicago Company Overview 306
5.135.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 306
5.136 University of South Florida Company Overview 307
5.136.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 307
5.137 University of Tokyo Company Overview 309
5.137.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 309
5.138 University of Toronto Company Overview 310
5.138.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview 310
5.139 University of Washington Company Overview 311
5.139.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 311
5.140 Vaxess Technologies Inc Company Overview 312
5.140.1 Vaxess Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 312
5.141 Vaxxas Pty Ltd Company Overview 316
5.141.1 Vaxxas Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 316
5.142 Verndari Inc Company Overview 317
5.142.1 Verndari Inc Pipeline Products & Ongoing Clinical Trials Overview 317
5.143 ViiV Healthcare UK Ltd Company Overview 318
5.143.1 ViiV Healthcare UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 318
5.144 Virpax Pharmaceuticals Inc Company Overview 319
5.144.1 Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 319
5.145 Vyteris, Inc. (Inactive) Company Overview 323
5.145.1 Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 323
5.146 Wellfully Ltd Company Overview 324
5.146.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview 324
5.147 Xel Pharmaceuticals Inc Company Overview 325
5.147.1 Xel Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 325
5.148 XPhyto Therapeutics Corp Company Overview 329
5.148.1 XPhyto Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 329
5.149 Zambon Italia Srl Company Overview 330
5.149.1 Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview 330
5.150 Z-Cube Srl Company Overview 331
5.150.1 Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview 331
5.151 ZetrOZ Inc Company Overview 332
5.151.1 ZetrOZ Inc Pipeline Products & Ongoing Clinical Trials Overview 332
5.152 Zosano Pharma Corp Company Overview 333
5.152.1 Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 333
5.153 Zylo Therapeutics LLC Company Overview 335
5.153.1 Zylo Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 335
5.154 Zynerba Pharmaceuticals Inc Company Overview 336
5.154.1 Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 336
6 Transdermal Drug Delivery- Recent Developments 337
6.1 Jul 18, 2022: GSK Notice of General Meeting 337
6.2 Jul 06, 2022: Aequus signs exclusive distribution agreement with SCOPE Ophthalmics for Canadian distribution rights of dry eye products 337
6.3 Jul 01, 2022: Aequus Provides General Update and Reports Record 2021 Financial Results 337
6.4 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 338
6.5 Jun 03, 2022: Lilly to Participate in Goldman Sachs Global Healthcare Conference 339
6.6 Jun 03, 2022: Eli Lilly announces its new president and general manager for Latam 339
6.7 May 30, 2022: GSK announces further appointments to designate Haleon Board 339
6.8 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 341
6.9 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 341
6.10 May 16, 2022: Miravo Healthcare Announces First Quarter 2022 Results 341
6.11 May 12, 2022: Camurus’ interim report January-March 2022 344
6.12 May 10, 2022: 3M Annual Meeting Highlights Strong 2021, Investments for Future 345
6.13 May 06, 2022: Mary Lynne Hedley Elected to Lilly Board of Directors 346
6.14 May 04, 2022: Dyve Biosciences to Present at the UBS Global Healthcare Conference 347
6.15 May 03, 2022: Lilly to Participate in Bank of America Securities 2022 Healthcare Conference 347
6.16 May 03, 2022: Receipt of Research & Development Tax Incentive 348
6.17 May 02, 2022: Miravo Healthcare Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of Shareholders 348
6.18 Apr 28, 2022: UCB’s General Meeting of Shareholders 2022 349
6.19 Apr 27, 2022: GlaxoSmithKline announces 1st Quarter Results 350
6.20 Apr 22, 2022: Aequus Announces Director Resignation 351
6.21 Apr 11, 2022: KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference 351
6.22 Apr 06, 2022: Camurus annual report for 2021 351
6.23 Mar 30, 2022: Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update 352
6.24 Mar 28, 2022: Norgine announces appointment of Alan Butcher as Chief Corporate Development Officer 354
6.25 Mar 28, 2022: Miravo Healthcare Announces 2021 and Fourth Quarter Results 354
6.26 Mar 28, 2022: GlaxoSmithKline announces Publication of 2022 AGM Notice 357
6.27 Mar 28, 2022: Norgine B.V. announces appointment of Alan Butcher as Chief Corporate Development Officer 358
6.28 Mar 23, 2022: LTS announces retirement of Werner Luscher and the appointment of Ulrich Sielaff as the company’s Chief Financial Officer 358
6.29 Mar 23, 2022: DURECT Corp. to Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit 359
6.30 Mar 15, 2022: GSK announces appointments to Designate Haleon Board 359
6.31 Mar 15, 2022: GlaxoSmithKline announces Appointments to Designate Haleon Board 362
6.32 Mar 10, 2022: Watson Pharmaceutical Announces Postponing the Replacement and Election of Independent Directors 365
6.33 Mar 07, 2022: Durect Reports Fourth Quarter and Full Year 2021 Financial Results and Update of Programs 365
6.34 Mar 04, 2022: Glaxosmithkline Announces Publishes Annual Report 2021 366
6.35 Mar 02, 2022: Sumitomo Dainippon Pharma Announces Changes in Executive Officers Including Representative Director, Organizational Realignment and Personnel Changes 367
6.36 Feb 28, 2022: Miravo Healthcare to Present at Q1 Virtual Investor Summit 367
6.37 Feb 28, 2022: Revance Reports Fourth Quarter and Full Year 2021 Financial Results, Provides Corporate Update 367
6.38 Feb 09, 2022: GlaxoSmithKline announces Final Results 369
6.39 Jan 25, 2022: 3M Reports Fourth-Quarter and Full-Year 2021 Results 372
6.40 Jan 22, 2022: 3M MMM to Release Earnings on Tuesday 375
6.41 Jan 19, 2022: Tony Wood appointed Chief Scientific Officer designate, GSK 375
6.42 Jan 18, 2022: Nutriband expands product development pipeline for its AVERSA platform abuse deterrent technology 377
6.43 Jan 11, 2022: GSK elevates marketing’s role with key senior leadership appointments 377
6.44 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 378
6.45 Dec 17, 2021: Norgine announces Senior Management changes 378
6.46 Dec 17, 2021: Norgine Announces Senior Management changes 378
6.47 Dec 14, 2021: DURECT Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter Garcia 379
6.48 Nov 30, 2021: GSK appoints Phil Dormitzer M.D., Ph.D., as Global Head of Vaccines R&D 379
6.49 Nov 16, 2021: Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients 380
6.50 Nov 15, 2021: Miravo Healthcare Announces Third Quarter 2021 Results 381
6.51 Nov 09, 2021: Revance Reports Third Quarter 2021 Financial Results, Provides Corporate Update 382
6.52 Nov 04, 2021: Antares Pharma Reports Third Quarter 2021 Financial and Operating Results 385
6.53 Nov 02, 2021: DURECT Corporation Reports financial results for the three months ended September 30, 2021 387
6.54 Oct 27, 2021: GlaxoSmithKline announces third Quarter Results 388
6.55 Oct 26, 2021: 3M Reports Third-Quarter 2021 Results 390
6.56 Oct 11, 2021: GSK unveils plan for UK headquarters of new Consumer Healthcare company 392
6.57 Oct 05, 2021: Norgine celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer 393
6.58 Sep 08, 2021: Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference 394
6.59 Aug 31, 2021: Lilly to Participate in Citi’s 16th Annual BioPharma Virtual Conference 394
6.60 Aug 17, 2021: SRDDS MOU between Samyang Holdings Biopharmaceuticals Division and G2GBIO 394
6.61 Aug 09, 2021: Miravo Healthcare Announces Second Quarter 2021 Results 395
6.62 Aug 05, 2021: Antares Pharma Reports Second Quarter 2021 Financial and Operating Results 397
6.63 Aug 05, 2021: Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update 399
6.64 Jul 29, 2021: Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021 401
6.65 Jul 28, 2021: Teva Reports Second Quarter 2021 Financial Results 401
6.66 Jul 28, 2021: Antares Pharma to Report Second Quarter 2021 Financial and Operating Results 403
6.67 Jul 28, 2021: 3m announces Half-year Report 404
6.68 Jul 27, 2021: 3M reports second-quarter 2021 results 405
6.69 Jul 26, 2021: Miravo Healthcare Announces Second Quarter 2021 Results Release Date and Conference Call Details 406
7 Appendix 408
7.1 Methodology 408
7.2 About GlobalData 411
7.3 Contact Us 411
7.4 Disclaimer 411
